| P2093 | author name string | M I Wilde | |
| | C M Spencer | |
| P2860 | cites work | Biochemical profile of midalcipran (F 2207), 1-phenyl-1-diethyl-aminocarbonyl-2-aminomethyl-cyclopropane (Z) hydrochloride, a potential fourth generation antidepressant drug | Q28287072 |
| | Preclinical pharmacology of milnacipran | Q28297082 |
| | Comparative studies with milnacipran and tricyclic antidepressants in the treatment of patients with major depression: a summary of clinical trial results | Q28297092 |
| | Milnacipran and selective serotonin reuptake inhibitors in major depression | Q28297103 |
| | A New Depression Scale Designed to be Sensitive to Change | Q29614720 |
| | Development of a Rating Scale for Primary Depressive Illness | Q29616244 |
| | Pharmacokinetics of milnacipran in liver impairment | Q34663566 |
| | Pharmacokinetics of milnacipran in renal impairment | Q34663571 |
| | Contemporary management of depression | Q40650598 |
| | Long-term management of depression | Q40650611 |
| | Cost-effectiveness considerations for managed care systems: treating depression in primary care | Q40650621 |
| | Interest of a loading dose of milnacipran in endogenous depressive inpatients. Comparison with the standard regimen and with fluvoxamine | Q41151529 |
| | Pharmacokinetics of milnacipran in comparison with other antidepressants | Q41219213 |
| | Clinical efficacy of milnacipran: placebo-controlled trials. | Q41219223 |
| | Efficacy and tolerability of milnacipran: an overview | Q41219240 |
| | Milnacipran, a new serotonin and noradrenaline reuptake inhibitor: an overview of its antidepressant activity and clinical tolerability. | Q41528264 |
| | Long-term efficacy and safety of milnacipran compared to clomipramine in patients with major depression | Q42545767 |
| | Controlled comparison of two doses of milnacipran (F 2207) and amitriptyline in major depressive inpatients | Q44358151 |
| | Psychopharmacology of midalcipran, 1-phenyl-1-diethyl-amino-carbonyl-2-aminomethylcyclopropane hydrochloride (F 2207), a new potential antidepressant | Q46203982 |
| | Electroencephalographic and cardiovascular effects of milnaciplan hydrochloride (TN-912), a novel antidepressant | Q46521868 |
| | Effect of antidepressant drugs on monoamine synthesis in brain in vivo | Q48464434 |
| | Effects of prolonged administration of milnacipran, a new antidepressant, on receptors and monoamine uptake in the brain of the rat | Q48544563 |
| | Measuring the side effects of psychotropics: the behavioural toxicity of antidepressants. | Q50795307 |
| | Serotonin reuptake inhibitors reduce conditioned fear stress-induced freezing behavior in rats. | Q51118616 |
| | A double-blind six months comparative study of milnacipran and clomipramine in major depressive disorder. | Q54147077 |
| | The efficacy of selective serotonin re-uptake inhibitors in depression: a meta-analysis of studies against tricyclic antidepressants | Q60621656 |
| | Monoamine uptake inhibition by plasma from healthy volunteers after single oral doses of the antidepressant milnacipran | Q69426451 |
| | Double-blind placebo-controlled study of milnacipran in hospitalized patients with major depressive disorders | Q69578248 |
| | Comparative in vivo and in vitro study of the cardiac effects of midalcipran and imipramine | Q69698368 |
| | 1-Aryl-2-(aminomethyl)cyclopropanecarboxylic acid derivatives. A new series of potential antidepressants | Q69729340 |
| | Lack of effect of repeated administration of milnacipran, a double noradrenaline and serotonin reuptake inhibitor, on the beta-adrenoceptor-linked adenylate cyclase system in the rat cerebral cortex | Q71719185 |
| | Autoradiographic characterization of binding sites for [3H]milnacipran, a new antidepressant drug, and their relationship to the serotonin transporter in rat brain | Q72128526 |
| | Acute electrophysiological effects of intravenous milnacipran, a new antidepressant agent | Q72249703 |
| | Effect of milnacipran and desipramine on noradrenergic alpha 2-autoreceptor sensitivity | Q72417057 |
| | Controlled comparison of milnacipran and fluoxetine in major depression | Q72521583 |
| | Double-blind study of the efficacy and safety of milnacipran and imipramine in elderly patients with major depressive episode | Q74364638 |
| P433 | issue | 3 | |
| P304 | page(s) | 405-427 | |
| P577 | publication date | 1998-09-01 | |
| P1433 | published in | Drugs | Q3040094 |
| P1476 | title | Milnacipran. A review of its use in depression | |
| P478 | volume | 56 | |